Genmab A/S - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US3723032062

SecurityGMAB / Genmab A/S - Depositary Receipt (Common Stock)
InstitutionWealth Alliance
Latest Disclosed Ownership13,615 shares
Latest Disclosed Value $ 365,299
Wealth Alliance reports 3.47% decrease in ownership of GMAB / Genmab A/S - Depositary Receipt (Common Stock)

On May 14, 2026 - Wealth Alliance filed a 13F-HR form disclosing ownership of 13,615 shares of Genmab A/S - Depositary Receipt (Common Stock) (US:GMAB) valued at $365,290 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 14,104 shares of Genmab A/S - Depositary Receipt (Common Stock). This represents a change in shares of -3.47% during the quarter. The current value of the position is $325,126 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GENMAB A SPONSORED ADS 372303206 13,615 -489 -3.47 365 -15.90 0.0361
2026-02-13 2025-12-31 13F GENMAB A SPONSORED ADS 372303206 14,104 -49 -0.35 434 0.00 0.0425
2025-11-07 2025-09-30 13F GENMAB A SPONSORED ADS 372303206 14,153 -302 -2.09 434 45.64 0.0446
2025-08-08 2025-06-30 13F GENMAB A SPONSORED ADS 372303206 14,455 327 2.31 299 7.97 0.0334
2025-05-05 2025-03-31 13F GENMAB A SPONSORED ADS 372303206 14,128 14,128 277 0.0335
2025-02-03 2024-12-31 13F GENMAB A SPONSORED ADS 372303206 0 -10,043 -100.00 0 -100.00
2024-11-04 2024-09-30 13F GENMAB A SPONSORED ADS 372303206 10,043 10,043 245 0.0292
2024-05-10 2024-03-31 13F GENMAB A SPONSORED ADS 372303206 0 -8,403 -100.00 0 -100.00
2024-01-30 2023-12-31 13F GENMAB A SPONSORED ADS 372303206 8,403 -2,298 -21.47 268 -29.18 0.0375
2023-11-09 2023-09-30 13F GENMAB A SPONSORED ADS 372303206 10,701 134 1.27 377 -5.99 0.0595
2023-08-02 2023-06-30 13F GENMAB A SPONSORED ADS 372303206 10,567 299 2.91 402 3.62 0.0601
2023-05-11 2023-03-31 13F GENMAB A SPONSORED ADS 372303206 10,268 119 1.17 388 -10.00 0.0628
2023-02-13 2022-12-31 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS ADR 372303206 10,149 -1,759 -14.77 430 12.27 0.0764
2022-11-14 2022-09-30 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS ADR 372303206 11,908 4,172 53.93 383 52.59 0.0756
2022-10-11 2022-06-30 13F/A-1 GENMAB AS SPON ADS EACH REP 0.1 ORD SHS ADR 372303206 7,736 -1,636 -17.46 251 -25.96 0.0482
2022-08-15 2022-06-30 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS ADR 372303206 7,736 -1,636 251 0.0305
2022-05-10 2022-03-31 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS ADR 372303206 9,372 552 6.26 339 -2.87 0.0483
2022-02-14 2021-12-31 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS ADR 372303206 8,820 -1,150 -11.53 349 -19.95 0.0702
2021-11-12 2021-09-30 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS ADR 372303206 9,970 2,074 26.27 436 35.40 0.0979
2021-08-16 2021-06-30 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS ADR 372303206 7,896 -1,803 -18.59 322 1.26 0.0758
2021-05-18 2021-03-31 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS ADR 372303206 9,699 -408 -4.04 318 -22.63 0.0891
2021-02-11 2020-12-31 13F GENMAB A ADR 372303206 10,107 416 4.29 411 15.77 0.1211
2020-12-01 2020-09-30 13F/A-1 GENMAB A ADR 372303206 9,691 -558 -5.44 355 2.31 0.1276
2020-11-13 2020-09-30 13F GENMAB A ADR 372303206 9,691 -558 355 104,418.2141
2020-08-14 2020-06-30 13F GENMAB A ADR 372303206 10,249 10,249 347 0.1371
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.